Brian M Gilfix
Overview
Explore the profile of Brian M Gilfix including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
146
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Quispialaya K, Therriault J, Aliaga A, Tissot C, Servaes S, Rahmouni N, et al.
Eur J Neurol
. 2024 Oct;
31(12):e16255.
PMID: 39447157
Background And Purpose: This study was undertaken to compare the performance of plasma p-tau181 with that of [F]fluorodeoxyglucose (FDG) positron emission tomography (PET) in the identification of early biological Alzheimer...
2.
Bauer W, Watkins D, Zacharias C, Gilfix B, Rosenblatt D
Mol Genet Metab
. 2023 Dec;
141(1):108111.
PMID: 38103461
Methionine dependence, the inability to grow in culture when methionine in the medium is replaced by its metabolic precursor homocysteine, occurs in many tumor cell lines. In most affected lines,...
3.
Dibernardo A, Toledo N, Robinson A, Osiowy C, Giles E, Day J, et al.
J Assoc Med Microbiol Infect Dis Can
. 2022 Nov;
7(3):186-195.
PMID: 36337598
Background: Serological assays designed to detect SARS-CoV-2 antibodies are being used in serological surveys and other specialized applications. As a result, and to ensure that the outcomes of serological testing...
4.
Sorin M, Watkins D, Gilfix B, Rosenblatt D
Mol Genet Metab
. 2021 Jan;
132(3):155-161.
PMID: 33487542
Methionine dependence of tumor cell lines, the inability to grow in tissue culture media lacking methionine but supplemented with homocysteine, has been known for decades, but an understanding of the...
5.
Bidla G, Rosenblatt D, Gilfix B
J Appl Lab Med
. 2020 Dec;
6(3):715-728.
PMID: 33331634
Background: Alpha-1-antitrypsin deficiency (AATD) is one of the most common hereditary disorders occurring in populations of European origin and is due to variants in SERPINA1, which encodes a protease inhibitor...
6.
Bidla G, Watkins D, Chery C, Froese D, Ells C, Kerachian M, et al.
Mol Genet Metab
. 2020 May;
130(3):179-182.
PMID: 32414565
MTHFD1 is a trifunctional protein containing 10-formyltetrahydrofolate synthetase, 5,10-methenyltetrahydrofolate cyclohydrolase and 5,10-methylenetetrahydrofolate dehydrogenase activities. It is encoded by MTHFD1 and functions in the cytoplasmic folate cycle where it is involved...
7.
Mattman A, Gilfix B, Chen S, DeMarco M, Kyle B, Parker M, et al.
Clin Biochem
. 2020 May;
81:27-33.
PMID: 32387440
Background: Laboratory confirmation of alpha-1-antitrypsin (A1AT) deficiency may be achieved by multiple methods. Here, we compare the relative comprehensiveness and efficiency of pathogenic variant (PV) detection of four different protocols...
8.
Chen T, Gilfix B, Rivera J, Sadeghi N, Richardson K, Hier M, et al.
Thyroid
. 2020 Apr;
30(9):1280-1287.
PMID: 32242511
Although the current gold standard for diagnosing thyroid nodule malignancy is ultrasound-guided fine-needle aspiration (FNA) cytology, about 20-25% of cytological evaluations are considered indeterminate for malignancy. This limitation has led...
9.
Brasell E, Chu L, Akpa M, Eshkar-Oren I, Alroy I, Corsini R, et al.
PLoS One
. 2019 Dec;
14(12):e0223954.
PMID: 31800572
Background: Cystinosis is a rare disorder caused by recessive mutations of the CTNS gene. Current therapy decreases cystine accumulation, thus slowing organ deterioration without reversing renal Fanconi syndrome or preventing...
10.
Gilfix B
Hum Mutat
. 2019 Aug;
40(8):1010-1012.
PMID: 31374155
The congenital disorders of glycosylation are a diverse group of disorders, which present both common and unique challenges in the diagnosis of rare disorders. These disorders affect a variety of...